Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04697888 · ClinicalTrials.gov registry record · Phase 2
Use of Omegaven for Treatment With Parenteral Nutrition Associated Liver Disease
A Phase 2 study of Parenteral Nutrition-related Hepatitis, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- Phase 2
- Development phase
- 2
- Enrollment target
- 1
- Study location
NCT04697888: Completed Phase 2 study of Parenteral Nutrition-related Hepatitis, sponsored by Children's Mercy Hospital Kansas City.
NCT04697888 is a Phase 2 study of Parenteral Nutrition-related Hepatitis that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 2 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04697888, a Phase 2 study of Parenteral Nutrition-related Hepatitis, has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 2 participants
- Enrollment target
- 1
- Study location
Study Summary
To provide parenteral fat emulsion prepared from fish oil (omega-3 fatty acid emulsion, Omegaven®) to patients with liver disease (PNALD).
Primary Outcome
To evaluate whether established parenteral nutrition associated liver disease (PNALD) can be reversed or its progression halted by using a parenteral fat emulsion prepared from fish oil (omega-3 fatty acid emulsion, Omegaven®) as measured by normalization or decrease of serum levels of hepatic enzymes.
Conditions Studied
Interventions
- DRUG Omegaven
Study Locations (1)
Missouri
- Children's Mercy Hospitals and Clinics - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2013-04 |
| Est. Completion | 2018-11 |
| Phase | Phase 2 |
What the finished NCT04697888 record still lists
NCT04697888 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Parenteral Nutrition-related Hepatitis appearing as the primary indexed condition, and to 1 intervention - of which Omegaven is the first listed.
NCT04697888 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT04697888 about?
NCT04697888 is a clinical study titled "Use of Omegaven for Treatment With Parenteral Nutrition Associated Liver Disease". To provide parenteral fat emulsion prepared from fish oil (omega-3 fatty acid emulsion, Omegaven®) to patients with liver disease (PNALD).
What is the current status of trial NCT04697888?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 2 participants. The study started on 2013-04. Estimated completion is 2018-11.
What conditions does trial NCT04697888 study?
This clinical trial studies the following conditions: Parenteral Nutrition-related Hepatitis.
What interventions are being tested in trial NCT04697888?
The interventions under investigation include: Omegaven (DRUG).
Who is sponsoring clinical trial NCT04697888?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04697888 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04697888's enrollment target sits among peer trials
2 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia